Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2006; 12(18): 2919-2922
Published online May 14, 2006. doi: 10.3748/wjg.v12.i18.2919
Published online May 14, 2006. doi: 10.3748/wjg.v12.i18.2919
Figure 1 A: On MRCP of a patient with autoimmune pancreatitis, 2 segmentally skipped lesions of the main pancreatic duct in the head and body of the pancreas were not visualized; B: After steroid therapy, the entire MPD was seen on MRCP.
Figure 2 A: On T1-weighted MR images of a patient with autoimmune pancreatitis, the signal intensity of the affected pancreatic lesion was slightly decreased compared to the signal intensity in the liver; B: T2-weighted MR images showed increased signal intensity in the pancreatic parenchyma than that of the liver with a capsule-like rim which was hypointense; C: After steroid therapy, the enlarged pancreas became atrophic on T1-weighted MR images.
- Citation: Kamisawa T, Chen PY, Tu Y, Nakajima H, Egawa N, Tsuruta K, Okamoto A, Kamata N. MRCP and MRI findings in 9 patients with autoimmune pancreatitis. World J Gastroenterol 2006; 12(18): 2919-2922
- URL: https://www.wjgnet.com/1007-9327/full/v12/i18/2919.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i18.2919